Digital health funding dropped 76%. This isn't a market correction—it's a reckoning - Episode 97 скачать в хорошем качестве

Digital health funding dropped 76%. This isn't a market correction—it's a reckoning - Episode 97

Why Silicon Valley's favorite mantra destroys healthcare companies—and what actually scales instead. "Move fast and break things" works brilliantly for social media apps. In healthcare, it's not just ineffective—it's dangerous. In this episode, we dissect why digital health funding dropped 76% from its 2021 peak and reveal the real reason healthcare startups fail. What you'll learn: Why the #1 cause of digital health startup failure isn't funding or competition The hidden cost of launching before clinical validation (backed by research) What Theranos teaches us about weaponizing speed in healthcare The alternative framework: "Build slowly, validate obsessively, scale deliberately" How Epic Systems and Tempus built billion-dollar companies by moving right, not fast Key stats covered: Average FDA clearance timeline: 177 days (and why that's actually your moat) Only 2.7% of diabetes apps have peer-reviewed evidence Companies with FDA clearance have 3.2X higher survival rates This isn't about being slow—it's about being strategic. Because in healthcare, the graveyard is full of companies that moved fast. The winners moved right. 🔔 Subscribe for weekly insights on healthcare innovation that actually works 💬 What's your biggest challenge in healthcare product development? Comment below. Timestamps: 0:00 - Intro: The seductive lie of "move fast" 0:45 - Why digital health funding crashed 76% 3:12 - The Theranos case study: What really went wrong 5:30 - Why healthcare rejects speed (regulatory reality) 8:15 - The cost of being wrong in healthcare 10:20 - What actually scales: Clinical validation first 13:45 - Real examples: Epic Systems & Tempus 14:50 - Your competitive advantage #HealthcareInnovation #DigitalHealth #StartupStrategy #HealthTech #ClinicalValidation